Not applicableUnknownNCT02512250What this trial is testingSwiss Hemophilia RegistryWho this might be right forHemophilia and Other Severe Bleeding Disorders Swiss Hemophilia Network 900
Not applicableUnknownNCT00573118What this trial is testingSevere Pregnancy Complications Are Associated With Elevated Factor VIII Plasma ActivityWho this might be right forPregnancy ComplicationsPreeclampsiaPlacental Abruption+2 more Tel-Aviv Sourasky Medical Center 100
Post-approval studies (Phase 4)Study completedNCT03103542What this trial is testingStudy of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI TherapiesWho this might be right forHemophilia A Swedish Orphan Biovitrum 16
Large-scale testing (Phase 3)Study completedNCT02263469What this trial is testingInvestigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 YearsWho this might be right forHaemophilia B Bio Products Laboratory
Not applicableEnrolling By InvitationNCT06816953What this trial is testingCartilage Biomarkers and HEAD-US Score in Severe Hemophilia A Patients Receiving FVIII ProphylaxisWho this might be right forHemophilia A Chulalongkorn University 19
Testing effectiveness (Phase 2)Study completedNCT04073498What this trial is testingThe Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)Who this might be right forHemophilia aHemophilia B ApcinteX Ltd 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416What this trial is testingKN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without InhibitorsWho this might be right forHemophilia a and B Suzhou Alphamab Co., Ltd. 24
Large-scale testing (Phase 3)WithdrawnNCT06297486What this trial is testingStudy of a Gene Therapy Treatment for Hemophilia AWho this might be right forHemophilia A Spark Therapeutics, Inc.
Not applicableStudy completedNCT05568524What this trial is testingResistance Training With Blood Flow Restriction in HemophiliaWho this might be right forHemophilia University of Valencia 20
Testing effectiveness (Phase 2)Study completedNCT05265286What this trial is testingRepeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for InjectionWho this might be right forSevere Hemophilia A Jiangsu Gensciences lnc. 15
Early research (Phase 1)Study completedNCT00952822What this trial is testingPharmacokinetic Study of ADVATE Reconstituted in 2 mL Sterile Water for InjectionWho this might be right forHemophilia A Baxalta now part of Shire 52
Post-approval studies (Phase 4)Study completedNCT01085344What this trial is testingCanadian Hemophilia Prophylaxis StudyWho this might be right forSevere Hemophilia A The Hospital for Sick Children 56
Early research (Phase 1)Looking for participantsNCT06703606What this trial is testingLearn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.Who this might be right forSevere Hemophilia A Pfizer 15
Large-scale testing (Phase 3)Study completedNCT01335061What this trial is testingStudy To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia BWho this might be right forHemophilia B Pfizer 25
Not applicableStudy completedNCT02319070What this trial is testing2-cohort Study of Adult Patients With Severe Hemophilia A in GreeceWho this might be right forHemophilia A Bayer 72
Post-approval studies (Phase 4)Study completedNCT02697370What this trial is testingEfficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia AWho this might be right forSevere Haemophilia A Hampshire Hospitals NHS Foundation Trust 20
Large-scale testing (Phase 3)Study completedNCT04759131What this trial is testingSafety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia AWho this might be right forHemophilia A Bioverativ, a Sanofi company 74
Testing effectiveness (Phase 2)Study completedNCT00989196What this trial is testingClinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia AWho this might be right forHemophilia A Octapharma 22
Not applicableUnknownNCT02324517What this trial is testingEx Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding DisordersWho this might be right forSevere Hemophilia Sheba Medical Center 300
Large-scale testing (Phase 3)Study completedNCT01945593What this trial is testingBAX 855 ContinuationWho this might be right forHemophilia A Baxalta now part of Shire 218